Internal Medicine, Gastroenterology · Shreveport, LA
NPI
1922202597
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
4
Medicare group memberships
Hospitals
4
Hospital affiliations
8001 Youree Dr Ste 540
Shreveport, LA, 71115
Phone (318) 631-9121
Groups this clinician bills Medicare through
Medicare paid, 2024
$280K
7,673 services
Medicare patients, 2024
754
Average age 74
Drug cost, 2024
$1.3M
1,624 prescriptions
Company payments, 2025
$868
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sathya Jaganmohan was code J3380 (injection, vedolizumab, intravenous, 1 mg), 5,400 times for 12 patients. In total Sathya Jaganmohan billed 7,673 services in 63 codes, and Medicare paid $280K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 5,400 | 12 | $17.28 | $93K |
| 43239 Upper GI Endoscopy | Facility | 313 | 298 | $43.07 | $13K |
| 45385 Colonoscopy - Lesion Removal | Facility | 132 | 132 | $174.23 | $23K |
| 45380 Lower GI Endoscopy - Other | Facility | 112 | 111 | $107.65 | $12K |
| 43237 Upper GI Endoscopy | Facility | 97 | 96 | $129.50 | $13K |
| 43249 Upper GI Endoscopy | Facility | 97 | 87 | $92.74 | $8,996 |
| 99232 Hospital E&M - Subsequent | Facility | 92 | 70 | $58.39 | $5,372 |
| 88305 Surgical Pathology Examination | Office | 84 | 40 | $24.63 | $2,069 |
| 43238 Upper GI Endoscopy | Facility | 79 | 75 | $155.51 | $12K |
| 99222 Hospital E&M - Initial | Facility | 59 | 59 | $96.22 | $5,677 |
| 43264 Upper GI Endoscopy | Facility | 51 | 38 | $77.16 | $3,935 |
| 76981 Ultrasound - Nonspecific | Office | 49 | 48 | $70.99 | $3,478 |
| 99223 Hospital E&M - Initial | Facility | 45 | 44 | $127.04 | $5,717 |
| 43274 Upper GI Endoscopy | Facility | 40 | 29 | $287.65 | $12K |
| 45390 Lower GI Endoscopy - Other | Facility | 39 | 39 | $246.60 | $9,618 |
By year: 2022 $336K for 7,895 services; 2023 $357K for 9,770 services; 2024 $280K for 7,673 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 84 | 40 | $24.63 | $2,069 |
| 88312 Surgical Pathology Examination | 24 | 16 | $60.04 | $1,441 |
| 82272 Immunoassay | 21 | 21 | $4.15 | $87.15 |
| 88313 Surgical Pathology Examination | 17 | 13 | $49.23 | $837 |
Medicare prescription drug claims, 2024
In 2024, the drug Sathya Jaganmohan prescribed most often to Medicare patients was Pantoprazole Sodium, with 361 prescriptions and refills. In total Sathya Jaganmohan wrote 1,624 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 361 | 734 | 158 | $4,532 |
| Omeprazole Generic | 255 | 493 | 112 | $3,120 |
| Sucralfate Generic | 94 | 136 | 44 | $2,070 |
| Creon Lipase/Protease/Amylase | 92 | 121 | 44 | $286K |
| Dicyclomine Hcl Generic | 78 | 95 | 33 | $870 |
| Linzess Linaclotide | 73 | 111 | 26 | $57K |
| Ondansetron Odt Ondansetron | 57 | 60 | 27 | $993 |
| Lansoprazole Generic | 34 | 44 | 14 | $1,166 |
| Famotidine Generic | 32 | 80 | 17 | $497 |
| Zenpep Lipase/Protease/Amylase | 27 | 39 | 11 | $156K |
| Colestipol Hcl Generic | 26 | 45 | 15 | $2,676 |
| Metoclopramide Hcl Generic | 26 | 36 | 20 | $96.17 |
| Amitriptyline Hcl Generic | 21 | 28 | 11 | $80.25 |
| Fluconazole Generic | 18 | 18 | 17 | $118 |
| Esomeprazole Magnesium Generic | 17 | 25 | Under 11 | $279 |
Brand drugs: - claims; generic drugs: 1,218 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sathya Jaganmohan $868 ($868 in general payments such as food, travel and fees) from 8 companies. The largest payer was Boston Scientific Corporation with $553.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.